MLICM
ACMR icon

Metropolitan Life Insurance Company (MetLife)’s ACM Research ACMR Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ACMR Stock Details ACMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,660
Closed -$77.5K – 35
2024
Q1 		$77.5K Hold
2,660
– – ﹤0.01% 1188
2023
Q4 		$52K Hold
2,660
– – ﹤0.01% 1429
2023
Q3 		$48.2K Hold
2,660
– – ﹤0.01% 1424
2023
Q2 		$34.8K Buy
2,660
+486
+22% +$5.12K ﹤0.01% 1641
2023
Q1 		$25.4K Sell
2,174
-734
-25% -$8.49K ﹤0.01% 1754
2022
Q4 		$22.4K Hold
2,908
– – ﹤0.01% 1954
2022
Q3 		$36.2K Hold
2,908
– – ﹤0.01% 1684
2022
Q2 		$48.9K Buy
+2,908
New +$44.8K ﹤0.01% 1532

Other funds holding ACMR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ACMR Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of ACM Research (ACMR) in Q2 2024, closing a stake of 2,660 shares — an estimated $77.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ACMR in Q2 2022 and held it in 8 quarters. The position peaked at $77.5K in Q1 2024. 201 funds tracked by Wall St. Rank hold ACMR as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining ACM Research position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,660 ACM Research shares in Q2 2024, an estimated $77.5K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in ACM Research in Q2 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s ACM Research position peaked at $77.5K in Q1 2024.
  • 201 funds tracked by Wall St. Rank held ACM Research as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.